ENMI Stock Overview
Through its subsidiary, Ho Shun Yi Limited, engages in the sale and distribution of COVID-19 rapid antigen tester sets in Hong Kong.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
DH Enchantment, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0014 |
| 52 Week High | US$0.08 |
| 52 Week Low | US$0.0006 |
| Beta | 24.51 |
| 11 Month Change | 0% |
| 3 Month Change | 40.00% |
| 1 Year Change | n/a |
| 33 Year Change | -99.65% |
| 5 Year Change | 27,900.00% |
| Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| ENMI | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -0.9% | 0.5% |
| 1Y | n/a | 2.7% | 23.9% |
Return vs Industry: Insufficient data to determine how ENMI performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how ENMI performed against the US Market.
Price Volatility
| ENMI volatility | |
|---|---|
| ENMI Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.5% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.4% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: ENMI's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine ENMI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 3 | Sally Lo | n/a |
DH Enchantment, Inc., through its subsidiary, Ho Shun Yi Limited, engages in the sale and distribution of COVID-19 rapid antigen tester sets in Hong Kong. It primarily serves as a personal hygiene products distributor. The company was formerly known as Energy Management International, Inc. and changed its name DH Enchantment, Inc. in August 2021.
DH Enchantment, Inc. Fundamentals Summary
| ENMI fundamental statistics | |
|---|---|
| Market cap | US$1.16m |
| Earnings (TTM) | -US$110.05k |
| Revenue (TTM) | US$1.88k |
619.7x
P/S Ratio-10.6x
P/E RatioIs ENMI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ENMI income statement (TTM) | |
|---|---|
| Revenue | US$1.88k |
| Cost of Revenue | -US$611.00 |
| Gross Profit | US$2.49k |
| Other Expenses | US$112.54k |
| Earnings | -US$110.05k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00013 |
| Gross Margin | 132.53% |
| Net Profit Margin | -5,860.12% |
| Debt/Equity Ratio | -44.8% |
How did ENMI perform over the long term?
See historical performance and comparison